No evidence-based guidelines are available for the treatment of Factor VII deficiency. Replacement therapy (RT) is still influenced by different factors as rarity of the disorder, availability and supply of products and economic reasons. All RTs are not exempt of side effects and scanty data is available about the safety of the products currently used. Aim of this study was to analyze adverse events (AEs) of RTs for congenital Factor VII deficiency, as reported in Seven Treatment Evaluation Registry (STER).
Mariani, G., Napolitano, M., Dolce, A., Bertrand, M., Charoenkwan, P., Micic, D., et al. (2012). Adverse Events in Treatment of Inherited Factor VII Deficiency: Final Analysis of the STER. ??????? it.cilea.surplus.oa.citation.tipologie.CitationProceedings.prensentedAt ??????? American Society of Hematology, atlanta.
Adverse Events in Treatment of Inherited Factor VII Deficiency: Final Analysis of the STER
NAPOLITANO, Mariasanta;SIRAGUSA, Sergio;
2012-01-01
Abstract
No evidence-based guidelines are available for the treatment of Factor VII deficiency. Replacement therapy (RT) is still influenced by different factors as rarity of the disorder, availability and supply of products and economic reasons. All RTs are not exempt of side effects and scanty data is available about the safety of the products currently used. Aim of this study was to analyze adverse events (AEs) of RTs for congenital Factor VII deficiency, as reported in Seven Treatment Evaluation Registry (STER).
| File | Dimensione | Formato | |
|---|---|---|---|
|
poster ASH 2012.doc
accesso aperto
Descrizione: POSTER PRESENTATION
Dimensione
20 kB
Formato
Microsoft Word
|
20 kB | Microsoft Word | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
